News
Pfizer Just Did This for the First Time in 6 Quarters. Time to Buy?
Just a couple of years ago, Pfizer's (NYSE: PFE) revenue was soaring thanks to sales of its coronavirus vaccine. In fact, the vaccine became the world's best-selling pharmaceutical product and even
Pfizer (PFE) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
Pfizer (NYSE: PFE)Q2 2024 Earnings CallJul 30, 2024, 10:30 a.m. ET
Operator
Source Fool.com
Prediction: This Will Be Pfizer's Next Big Move
Despite its impressive performance in 2020 and 2021, it's no secret that Pfizer (NYSE: PFE) is in the process of reinventing itself. Without much of the windfall from its coronavirus products
Got $5,000? These 3 Growth Stocks Are Incredibly Cheap Buys Right Now
Buying quality growth stocks doesn't have to involve paying an enormous premium. There are some solid, underrated companies worth buying right now that don't trade at egregious valuations. While
3 Stocks That Can Help You to Get Richer in 2024 and Beyond
If you're looking to invest in order to get richer, that's great -- because most of us need to be amassing a war chest for retirement (not to mention other financial goals, such as a down payment
Beware, Wegovy -- Pfizer Is Working on a Competitor
Which company is the leader in the burgeoning weight loss drug market? A recent poll found that among the largest drugmakers, Pfizer (NYSE: PFE) is the one Americans associate most with this
This Promising Weight Loss Drug Candidate Could Be a Huge Growth Catalyst for Pfizer
If there's one thing healthcare giant Pfizer (NYSE: PFE) really needs right now, it's a compelling growth catalyst. This year, the company isn't expecting much in the way of growth and investors are
This Ultra-High-Yield Dividend Stock Hits Yet Another Setback
Medical Properties Trust (NYSE: MPW) has been struggling because of tenant issues, which has made it more difficult for the real estate investment trust (REIT) to manage its large debt load. The
Better Dark Horse Weight Loss Drug Stock: Pfizer vs. Roche
Both Pfizer (NYSE: PFE) and Roche Holdings (OTC: RHHBY) rank among the world's most powerful pharmaceutical companies. Yet neither is actively competing in the all-important market for weight loss
UnitedHealth Group Rallies Despite Continued Cyberattack Cost Pressures. Is It Too Late to Buy the Stock?
Shares of UnitedHealth Group (NYSE: UNH) were rallying despite a past cyberattack on the company's Change Healthcare business continuing to affect the company's results. But with investors now
Could Pfizer Become a Top Weight Loss Drug Stock? Don't Count on It.
On July 11, Pfizer (NYSE: PFE) made an announcement that came as a bit of a surprise to biopharma industry experts and Wall Street analysts alike. It's planning on advancing one of its early-stage
Why UnitedHealth Stock Rocketed Nearly 7% Higher Today
A convincing bottom-line beat helped increase the share price of big health insurer UnitedHealth Group (NYSE: UNH) on Tuesday. Investors liked what they saw with the company's second-quarter
UnitedHealth Group (UNH) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
UnitedHealth Group (NYSE: UNH)Q2 2024 Earnings CallJul 16, 2024, 8:45 a.m. ET
Operator
Source Fool.com
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
Healthcare is an evergreen industry, meaning it will always be around. People will always need care, and naturally, they will strive for newer and better medicines and technologies to provide it
How Much Will UnitedHealth Group Pay Out in Dividends This Year?
UnitedHealth Group (NYSE: UNH) stock hasn't performed well this year so far, but there's a consolation prize for long-term investors. Every three months, UnitedHealth Group distributes a cash payout
History Says These Could Be 3 of the Best Healthcare Stocks to Own in the Second Half of 2024
The S&P 500 has remained red hot, achieving gains of nearly 15% through the first six months of 2024. Healthcare stocks have performed well, but not nearly to the same extent -- the Healthcare
2 Pharma Stocks to Buy Hand Over Fist This Month
Few pharmaceutical companies are more prominent than Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY). However, their popularity relative to most of their peers hasn't helped them much in the
Want $1,000 in Dividend Income? Here's How Much You Have to Invest in Pfizer Stock
Pfizer (NYSE: PFE) may not be the must-have pharmaceutical investment it was at one point. If your priority is reliable divided income, however, the drugmaker remains a rock-solid pick. Not only has
Down 55%, Is Pfizer a Good Dividend Stock to Buy on the Dip?
The past few years have been tough ones for investors holding shares of Pfizer (NYSE: PFE). The Big Pharma stock is down by more than half from the peak it set in late 2021.
Pfizer's stock price was
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With $100 in July
The benchmark S&P 500 index keeps breaking new records thanks in large part to a handful of stocks at the top. Luckily for income-seeking investors, there are some highly reliable dividend stocks
1 Underwhelming Stat That May Have You Thinking Twice About Buying Pfizer's Stock
Pfizer (NYSE: PFE) can be a polarizing stock to own right now. Its future remains hazy given that it is facing some troubling patent cliffs and revenue from its COVID-19 vaccine is dwindling. But at
2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
It's been a big year for most stocks, with the S&P 500 index up about 24% over the past 12 months. A rising market is wonderful for the stocks already in your portfolio, but finding new investment
2 Ultra-High-Yield Dividend Stocks Billionaires Are Buying Left and Right: Could They Be Smart Buys for You in July?
If you're an investor who doesn't already have access to billions in capital, you could probably learn a few things from the folks who do. Luckily, keeping tabs on the world's most successful
Is Pfizer Stock a Buy?
Shares of pharmaceutical giant Pfizer (NYSE: PFE) have been steadily sliding lower over the past year as revenue and profits from the pandemic's vaccine boom dry up. Today, the stock has seemingly
2 Beaten-Down Dividend Stocks With Yields Above 5% to Buy Now and Hold at Least a Decade
The benchmark S&P 500 index is up an exciting 25.8% over the past year, but many of its components haven't participated in the gains. Nvidia and other members of the "Magnificent Seven" have been